価格表
在庫・価格 : 2024年06月20日 02時40分 現在
商品名 | 商品コード | メーカー | 包装 | 価格 | 在庫 | リスト |
---|---|---|---|---|---|---|
Anti-GLP1R, Rabbit-Poly データシート |
NBP1-97308 |
NOVノバス バイオロジカルス Novus biologicals, LLC |
0.1 ml | ¥91,000 |
無 (未発注) |
追加 |
在庫・価格 : 2024年06月20日 02時40分 現在
使用文献
- No.: 1
-
文献情報:
Kedees MH et al. Functional activity of murine intestinal mucosal cells is regulated by the glucagon-like peptide-1 receptor. Peptides 2013 Oct;48:36-44
Kedees MH et al
2013/01/01
-
備考:
-
参照:
- No.: 2
-
文献情報:
Steven S et al. Glucagon-like peptide-1 receptor signalling reduces microvascular thrombosis, nitro-oxidative stress and platelet activation in endotoxaemic mice. Br. J. Pharmacol. 2016 Jul;
Steven S et al
2016/01/01
-
備考:
-
参照:
- No.: 3
-
文献情報:
Ihara M et al. An interaction between glucagon-like peptide-1 and adenosine contributes to cardioprotection of a dipeptidyl peptidase 4 inhibitor from myocardial ischemia-reperfusion injury. Am. J. Physiol. Heart Circ. Physiol. 2015 May;308(10):H1287-97
Ihara M et al
2015/01/01
-
備考:
-
参照:
- No.: 4
-
文献情報:
Tsutsumi Y et al. Combined Treatment with Exendin-4 and Metformin Attenuates Prostate Cancer Growth. PLoS ONE 2015;10(10):e0139709
Tsutsumi Y et al
2015/01/01
-
備考:
-
参照:
- No.: 5
-
文献情報:
Iwaya C et al. Exendin-4, a Glucagonlike Peptide-1 Receptor Agonist, Attenuates Breast Cancer Growth by Inhibiting NF-κB Activation. Endocrinology 2017 12;158(12):4218-4232
Iwaya C et al
2017/01/01
-
備考:
Species: Human, Applications: IHC-P -
参照:
- No.: 6
-
文献情報:
Wenjing H et al. Exendin-4 does not modify growth or apoptosis of human colon cancer cells. Endocr. Res. 2017 Aug;42(3):209-218
Wenjing H et al
2017/01/01
-
備考:
Species: Human, Applications: IHC -
参照:
- No.: 7
-
文献情報:
He W et al. Exendin-4 inhibits growth and augments apoptosis of ovarian cancer cells. Mol. Cell. Endocrinol. 2016 11;436:240-9
He W et al
2016/01/01
-
備考:
Species: Human, Applications: IHC -
参照:
- No.: 8
-
文献情報:
Chaudhari S et al. Inhibition of interleukin-6 on matrix protein production by glomerular mesangial cells and the pathway involved. Am J Physiol Renal Physiol 2020 06;318(6):F1478-F1488
Chaudhari S et al
2020/01/01
-
備考:
-
参照:
- No.: 9
-
文献情報:
Yang X et al. Mesenchymal stem cells combined with liraglutide relieve acute lung injury through apoptotic signaling restrained by PKA/β-catenin. Stem Cell Res Ther 2020 05;11(1):182
Yang X et al
2020/01/01
-
備考:
-
参照:
- No.: 10
-
文献情報:
Timper K et al. GLP-1 Receptor Signaling in Astrocytes Regulates Fatty Acid Oxidation, Mitochondrial Integrity, and Function. Cell Metab 2020 06;31(6):1189-1205.e13
Timper K et al
2020/01/01
-
備考:
-
参照:
- No.: 11
-
文献情報:
Feng Y et al. Effect of hCMSCs and liraglutide combination in ALI through cAMP/PKAc/β-catenin signaling pathway. Stem Cell Res Ther 2020 01;11(1):2
Feng Y et al
2020/01/01
-
備考:
-
参照:
- No.: 12
-
文献情報:
Deng H et al. Long-Term Liraglutide Administration Induces Pancreas Neogenesis in Adult T2DM Mice. Cell Transplant ;29:963689720927392
Deng H et al
-
備考:
-
参照:
- No.: 13
-
文献情報:
Nomiyama T et al. GLP-1 receptor agonist as treatment for cancer as well as diabetes: beyond blood glucose control. Expert Rev Endocrinol Metab 2016 Jul;11(4):357-364
Nomiyama T et al
2016/01/01
-
備考:
-
参照:
- No.: 14
-
文献情報:
Sho H et al. Insulinoma induces a hyperinsulinemia-mediated decrease of GLUT2 and GLP1 receptor in normal pancreatic β-cells. Biochem Biophys Res Commun 2021 01;534:702-706
Sho H et al
2021/01/01
-
備考:
-
参照:
- No.: 15
-
文献情報:
Nomiyama T et al. Exendin-4, a GLP-1 receptor agonist, attenuates prostate cancer growth. Diabetes 2014 Nov;63(11):3891-905
Nomiyama T et al
2014/01/01
-
備考:
-
参照: